Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $635.55 | 36 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $198.15 | 12 | $0 (2024) |
| Novo Nordisk Inc | $184.26 | 10 | $0 (2024) |
| Exact Sciences Corporation | $75.13 | 4 | $0 (2024) |
| Lilly USA, LLC | $52.27 | 3 | $0 (2024) |
| Amgen Inc. | $32.08 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $30.91 | 2 | $0 (2024) |
| Medtronic, Inc. | $25.54 | 1 | $0 (2023) |
| GlaxoSmithKline, LLC. | $20.28 | 1 | $0 (2024) |
| Eisai Inc. | $16.93 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $466.53 | 27 | ABBVIE INC. ($180.22) |
| 2023 | $169.02 | 9 | Novo Nordisk Inc ($88.37) |
All Payment Transactions
36 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/27/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $3.99 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: RESPIRATORY | ||||||
| 09/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Oncology | ||||||
| 08/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Obesity | ||||||
| 06/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: NEUROSCIENCE | ||||||
| 06/13/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Neurology | ||||||
| 05/31/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Obesity | ||||||
| 04/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: NEUROSCIENCE | ||||||
| 04/09/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Diabetes | ||||||
| 03/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.67 | General |
| Category: NEUROSCIENCE | ||||||
| 03/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Diabetes | ||||||
| 03/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Inflammation | ||||||
| 03/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: NEUROSCIENCE | ||||||
| 02/29/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Oncology | ||||||
| 02/08/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: NEUROSCIENCE | ||||||
| 02/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/29/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Inflammation | ||||||
| 01/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.95 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 488 | 737 | $135,024 | $36,350 |
| 2022 | 7 | 167 | 182 | $30,093 | $9,125 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 115 | 235 | $65,208 | $15,281 | 23.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 57 | 57 | $20,322 | $5,815 | 28.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 13 | 13 | $6,272 | $3,678 | 58.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 35 | 35 | $7,560 | $2,653 | 35.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 49 | 58 | $11,368 | $2,643 | 23.2% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 31 | 31 | $7,687 | $1,896 | 24.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $7,312 | $1,218 | 16.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 40 | 40 | $2,278 | $1,167 | 51.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 47 | 98 | $3,180 | $925.39 | 29.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 15 | 15 | $807.00 | $437.55 | 54.2% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 46 | 97 | $1,027 | $309.40 | 30.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 29 | $1,904 | $235.00 | 12.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 11 | 11 | $99.00 | $92.40 | 93.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 41 | 48 | $13,344 | $3,906 | 29.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 44 | 46 | $9,016 | $2,633 | 29.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $5,187 | $1,152 | 22.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 22 | 22 | $814.00 | $616.88 | 75.8% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2022 | 19 | 19 | $950.00 | $600.97 | 63.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 14 | 17 | $612.00 | $161.84 | 26.4% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 14 | 17 | $170.00 | $54.57 | 32.1% |
About Ryan King
Ryan King is a Family Medicine healthcare provider based in Goldsboro, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/01/2022. The National Provider Identifier (NPI) number assigned to this provider is 1023753407.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ryan King has received a total of $635.55 in payments from pharmaceutical and medical device companies, with $466.53 received in 2024. These payments were reported across 36 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($635.55).
As a Medicare-enrolled provider, King has provided services to 655 Medicare beneficiaries, totaling 919 services with total Medicare billing of $45,475. Data is available for 2 years (2022–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Goldsboro, NC
- Active Since 05/01/2022
- Last Updated 05/01/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1023753407
Products in Payments
- VRAYLAR (Drug) $137.80
- Ozempic (Drug) $81.74
- Cologuard Collection Kit (Device) $75.13
- QULIPTA (Drug) $56.36
- Wegovy (Drug) $52.79
- MOUNJARO (Drug) $52.27
- Rybelsus (Drug) $49.73
- Otezla (Drug) $32.08
- FARXIGA (Drug) $30.91
- INTELLIS ADAPTIVESTIM (Device) $25.54
- TRELEGY ELLIPTA (Drug) $20.28
- Leqembi (Drug) $16.93
- UBRELVY (Drug) $3.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Goldsboro
Dr. Dimitrios Lintzeris, D.o, D.O
Family Medicine — Payments: $110,192
Donald Clarke, Md, MD
Family Medicine — Payments: $13,159
Dr. Phillip Moye, M.d, M.D
Family Medicine — Payments: $10,278
Dr. Carolyn Sampson, M.d, M.D
Family Medicine — Payments: $5,597
Keith Carmack, M.d, M.D
Family Medicine — Payments: $3,631
Dr. Shannon Jimenez, D.o, D.O
Family Medicine — Payments: $3,496